WHIPPANY, N.J., March 13, 2018 /PRNewswire/ -- Bayer U.S. announced today that Raymond F. Kerins, Jr., Senior Vice President and Head of Communications, Government Relations & Policy, has been elected Vice Chairman of the U.S. Chamber of Commerce's Global Innovation Policy Center (GIPC). In this role, Kerins will serve as a leading voice in GIPC's efforts to support intellectual property standards that promote innovation and creativity, create jobs, save lives and advance economic and cultural prosperity.
Kerins, who has more than two decades of experience in helping global corporations communicate effectively and improve their reputations, joined Bayer in 2013. Kerins served in senior communications posts at Pfizer and Merck prior to Bayer.
"Ray is a creative, thoughtful and effective policy leader and communicator," said David Hirschmann, Chief Executive Officer of GIPC. "We are fortunate to welcome Ray as Vice Chairman as we work around the world to advance intellectual property-driven innovation. Ray, who also serves on the Board of Directors of the U.S. Chamber of Commerce, understands that consumers and businesses benefit from policies that incentivize companies to invest in research and innovation."
Kerins said he is humbled and honored to be GIPC's new Vice Chairman and looks forward to advocating on behalf of innovators.
"Intellectual property is the lifeblood of innovation," Kerins said. "A strong system that honors patents, trademarks, copyrights and trade secrets is the only sustainable way that will bring forward the latest lifesaving medical treatments and breakthrough technologies. I am proud to work with GIPC in fighting for strong IP rights that spur creativity, investment and job creation."
Kerins has long been recognized for his outstanding achievements in the public relations industry. Among his many honors are the "2017 Outstanding In-House Professional Award" by PRWeek Magazine and the "2010 Public Relations Professional of the Year" by PRWeek Magazine. He also currently serves on the U.S. Center for Disease Control & Prevention's Business Roundtable on Global Health Threats.
A lifelong New Yorker, Kerins is a graduate of Iona College, where he received B.A. and Master's degrees.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to www.bayer.us.
Social Media Channels
- Facebook: BayerUnitedStates
- Twitter: BayerUS
- Instagram: BayerUS
- YouTube: BayerUS
Bayer® and the Bayer Cross® are registered trademarks of Bayer.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.